Discovery Value Fund Gilead Sciences, Inc. Transaction History

Discovery Value Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $434,040 - $504,000	-6,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $375,780 - $481,320	6,000 New	6,000 $449,000
Q2 2019 Jul 25, 2019	SELL	$61.87 - $69.38 $593,395 - $665,423	-9,591 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $580,639 - $757,689	9,591 New	9,591 $600,000

1,924

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Discovery Value Fund, based on Form 13F filings with the SEC.

Stay updated on Discovery Value Fund with notifications on news.